$emis $ oral semaglutide
after good data of pioneer1 in t2d, $ confirms that the next step for oral semaglutide $emis could be in obesity
https://t.co/iw436hi4ev … "into the future, novo could “potentially” look at oral semaglutide in obesity, mr fruergaard jørgensen says"